{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:14:15Z","timestamp":1793794455567,"version":"4.6.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD023412"],"award-info":[{"award-number":["HD023412"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"University of Washington Center for AIDS Research","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cytomegalovirus (CMV) viremia is common in human immunodeficiency virus (HIV) infection and is associated with worse long-term outcomes. To date, no studies have assessed CMV viremia in children diagnosed with HIV in hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied CMV viremia and clinical outcomes in 163 Kenyan children aged 2 months to 12 years, diagnosed with HIV in hospital. CMV DNA levels in plasma were measured using quantitative polymerase chain reaction (PCR). Regression models were used to assess associations between CMV viremia \u22651000 IU\/mL and the risk of continued hospitalization or death at 15 days, duration of hospitalization, and 6-month mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At enrollment, 62\/114 (54%) children had CMV viremia, and 20 (32%) were \u22651000 IU\/mL. Eleven CMV reactivations were observed after admission. The prevalence and level of CMV viremia were highest in children &amp;lt;2 years and lowest in children \u22655 years old. CMV viremia \u22651000 IU\/mL was independently associated with age &amp;lt;2 years (P\u2005=\u2005.03), higher log10 HIV RNA level (P\u2005=\u2005.01), and height-for-age z score &amp;gt;\u22122 (P\u2005=\u2005.02). Adjusting for age and log10 HIV RNA, the relative risk of death or continued hospitalization at 15 days was 1.74 (95% confidence interval [CI]\u2005=\u20051.04, 2.90), and the hazard ratio of 6-month mortality was 1.97 (95% CI\u2005=\u2005.57, 5.07) for children with CMV DNA \u22651000 IU\/mL compared to lower-level or undetectable CMV DNA. Children with CMV DNA \u22651000 IU\/mL were hospitalized a median ~5 days longer than children with lower-level or undetectable CMV DNA (P\u2005=\u2005.002).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this nested observational study, CMV viremia was common in hospitalized children with HIV, and levels \u22651000 IU\/mL were associated with increased risk of mortality and longer hospitalization.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab604","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:46:18Z","timestamp":1625168778000},"page":"1237-1246","source":"Crossref","is-referenced-by-count":12,"title":["Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital"],"prefix":"10.1093","volume":"74","author":[{"given":"Dalton","family":"Wamalwa","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Njuguna","sequence":"additional","affiliation":[{"name":"Kenyatta National Hospital, Nairobi, Kenya"},{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Maleche-Obimbo","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Begnel","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy J","family":"Chebet","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A","family":"Onyango","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Marie","family":"Cranmer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meei-Li","family":"Huang","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Virology, Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Biostatistics, University of Washington, Seattle, Washington, USA"},{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boeckh","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"},{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-1573","authenticated-orcid":false,"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington, USA"},{"name":"Department of Medicine, University of Washington, Seattle, Washington, USA"},{"name":"Department of Pediatrics, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Slyker","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"2022040917421107600_CIT0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2055-6640(20)30873-6","article-title":"Cytomegalovirus and paediatric HIV infection","volume":"2","author":"Slyker","year":"2016","journal-title":"J Virus Erad"},{"key":"2022040917421107600_CIT0002","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fmicb.2015.01016","article-title":"Ongoing burden of disease and mortality from HIV\/CMV coinfection in Africa in the antiretroviral therapy era","volume":"6","author":"Adland","year":"2015","journal-title":"Front Microbiol"},{"key":"2022040917421107600_CIT0003","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/jiu417","article-title":"Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients","volume":"211","author":"Lichtner","year":"2015","journal-title":"J Infect Dis"},{"key":"2022040917421107600_CIT0004","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/cid\/ciz1001","article-title":"Cytomegalovirus seropositivity is associated with increased microbial translocation in people living with human immunodeficiency virus and uninfected controls","volume":"71","author":"Ramendra","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022040917421107600_CIT0005","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00179-19","article-title":"Subclinical cytomegalovirus DNA is associated with CD4 T cell activation and impaired CD8 T cell CD107a expression in people living with HIV despite early antiretroviral therapy","volume":"93","author":"Christensen-Quick","year":"2019","journal-title":"J Virol"},{"key":"2022040917421107600_CIT0006","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/QAD.0000000000001568","article-title":"Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants","volume":"31","author":"Garcia-Knight","year":"2017","journal-title":"AIDS"},{"key":"2022040917421107600_CIT0007","doi-asserted-by":"crossref","first-page":"11373","DOI":"10.1128\/JVI.00790-12","article-title":"Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants","volume":"86","author":"Slyker","year":"2012","journal-title":"J Virol"},{"key":"2022040917421107600_CIT0008","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199606063342302","article-title":"Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche cooperative oral ganciclovir study group","volume":"334","author":"Spector","year":"1996","journal-title":"N Engl J Med"},{"key":"2022040917421107600_CIT0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002030-199803000-00004","article-title":"A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn community programs for clinical research on AIDS","volume":"12","author":"Brosgart","year":"1998","journal-title":"AIDS"},{"key":"2022040917421107600_CIT0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/513804","article-title":"A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS clinical trials group protocol 204\/glaxo wellcome 123-014 international CMV prophylaxis study group","volume":"177","author":"Feinberg","year":"1998","journal-title":"J Infect Dis"},{"key":"2022040917421107600_CIT0011","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"},{"key":"2022040917421107600_CIT0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.qai.0000435256.34306.c1","article-title":"Impact of CMV therapy with valganciclovir on immune activation and the HIV viral load in semen and blood: an observational clinical study","volume":"65","author":"Shin","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022040917421107600_CIT0013","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1097\/QAD.0000000000000099","article-title":"Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children","volume":"27","author":"Ahmed","year":"2013","journal-title":"AIDS"},{"key":"2022040917421107600_CIT0014","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2352-3018(17)30167-4","article-title":"Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial","volume":"5","author":"Njuguna","year":"2018","journal-title":"Lancet HIV"},{"key":"2022040917421107600_CIT0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12887-015-0325-8","article-title":"High mortality in HIV-infected children diagnosed in hospital underscores need for faster diagnostic turnaround time in prevention of mother-to-child transmission of HIV (PMTCT) programs","volume":"15","author":"Wagner","year":"2015","journal-title":"BMC Pediatr"},{"key":"2022040917421107600_CIT0016","doi-asserted-by":"crossref","first-page":"18818","DOI":"10.7448\/IAS.17.1.18818","article-title":"Reasons for hospitalization in HIV-infected children in West Africa","volume":"17","author":"Dicko","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2022040917421107600_CIT0017","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/INF.0000000000001507","article-title":"Despite access to antiretrovirals for prevention and treatment, high rates of mortality persist among HIV-infected infants and young children","volume":"36","author":"Abrams","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2022040917421107600_CIT0018","author":"WHO."},{"key":"2022040917421107600_CIT0019","volume-title":"WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children","author":"WHO.","year":"2007"},{"key":"2022040917421107600_CIT0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/rmv.664","article-title":"CMV in critically ill patients: pathogen or bystander?","volume":"20","author":"Limaye","year":"2010","journal-title":"Rev Med Virol"},{"key":"2022040917421107600_CIT0021","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"2022040917421107600_CIT0022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"2022040917421107600_CIT0023","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cid\/ciy961","article-title":"Unexpectedly high prevalence of cytomegalovirus dnaemia in older children and adolescents with perinatally acquired human immunodeficiency virus infection","volume":"69","author":"Yindom","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022040917421107600_CIT0024","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/QAI.0000000000002012","article-title":"Brief report: cofactors of mortality among hospitalized HIV-infected children initiating antiretroviral therapy in Kenya","volume":"81","author":"Njuguna","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022040917421107600_CIT0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cid\/ciu853","article-title":"Prevalence and risk factors for betaherpesvirus DNAemia in children &gt;3 weeks and &lt;2 years of age admitted to a large referral hospital in sub-Saharan Africa","volume":"60","author":"Tembo","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022040917421107600_CIT0026","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/QAD.0b013e32833016e8","article-title":"Acute cytomegalovirus infection in Kenyan HIV-infected infants","volume":"23","author":"Slyker","year":"2009","journal-title":"AIDS"},{"key":"2022040917421107600_CIT0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199907083410203","article-title":"Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric pulmonary and cardiovascular complications of vertically transmitted HIV infection study group","volume":"341","author":"Kovacs","year":"1999","journal-title":"N Engl J Med"},{"key":"2022040917421107600_CIT0028","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00006454-199612000-00010","article-title":"Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1","volume":"15","author":"Doyle","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"2022040917421107600_CIT0029","first-page":"1127","article-title":"Rapid progression of HIV disease in children with cytomegalovirus DNAemia","volume":"10","author":"Nigro","year":"1996","journal-title":"AIDS"},{"key":"2022040917421107600_CIT0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12879-018-3195-5","article-title":"Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2022040917421107600_CIT0031","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study C.","year":"2015","journal-title":"Lancet"},{"key":"2022040917421107600_CIT0032","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/QAD.0000000000001579","article-title":"Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals","volume":"31","author":"Gianella","year":"2017","journal-title":"AIDS"},{"key":"2022040917421107600_CIT0033","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00167-18","article-title":"Subclinical cytomegalovirus infection is associated with altered host immunity, gut microbiota, and vaccine responses","volume":"92","author":"Santos Rocha","year":"2018","journal-title":"J Virol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab604\/40418039\/ciab604.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/7\/1237\/43350195\/ciab604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/7\/1237\/43350195\/ciab604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T17:42:54Z","timestamp":1649526174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/74\/7\/1237\/6313248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,2]]},"published-print":{"date-parts":[[2022,4,9]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab604","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,7,2]]}}}